Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety

被引:33
作者
Kim, IS [1 ]
Kim, SH [1 ]
机构
[1] Chosun Univ, Coll Pharm, Dept Biol Chem, Kwangju 501759, South Korea
基金
新加坡国家研究基金会;
关键词
polymeric nanoparticle; biotin; poly(ethylene glycol); lactobionic acid; all-trans-retinoic acid;
D O I
10.1016/S0378-5173(03)00128-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liver specific polymeric nanoparticles were designed and synthesized from biotinylated poly(ethylene glycol) conjugated with lactobionic acid containing a galactose moiety (abbreviated as BEL). Synthesized BEL conjugate was identified by Fourier transform-infrared (FT-IR) and H-1-nuclear magnetic resonance (NMR) spectroscopy. The fluorescence spectroscopy data showed that BEL conjugate was self-assembled in water to form core-shell structure nanoparticles, and the critical association concentration (CAC) value was estimated as 0.028 g/l. From the transmission electron microscope (TEM) observation, the BEL nanoparticles were spherically shaped and ranged in size between 30 and 60 nm. The particle size distribution was measured by photon correlation spectroscopy (PCS), and the result was 41.2+/-11.7 nm. Anti-cancer drug all-trans-retinoic acid (ATRA) was loaded into the BEL nanoparticles for evaluating its efficacy as a drug delivery carrier. The crystallinities of ATRA and ATRA-loaded nanoparticles were examined by X-ray diffraction (XRD) patterns. The ATRA release kinetics from the BEL nanoparticles showed a pseudo zero-order pattern during 1-month period. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 27 条
[1]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[2]   CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER [J].
ASHWELL, G ;
HARFORD, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :531-554
[3]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[4]  
CIECHANOVER A, 1983, J CELL BIOCHEM, V23, P107, DOI 10.1002/jcb.240230111
[5]   PHARMACOKINETIC CONSIDERATIONS IN TARGET-ORGAN DIRECTED DRUG DELIVERY [J].
DAEMEN, MJAP ;
SMITS, JFM ;
THIJSSEN, HHW ;
STRUYKERBOUDIER, HAJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (04) :138-141
[6]   THE OCCURRENCE AND PRODUCTION OF AVIDIN - A NEW CONCEPTION OF THE HIGH-AFFINITY BIOTIN-BINDING PROTEIN [J].
ELO, HA ;
KORPELA, J .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1984, 78 (01) :15-20
[7]  
GOTO M, 1994, J CONTROL RELEASE, V28, P223
[8]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[9]  
HAN S, 1996, J CLIN ENDOCR METAB, V81, P1
[10]   HEPATIC TARGETING OF DRUGS AND PROTEINS BY CHEMICAL MODIFICATION [J].
HASHIDA, M ;
NISHIKAWA, M ;
TAKAKURA, Y .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :99-107